FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3118166189> ?p ?o ?g. }

• W3118166189 endingPage "128" @default.
• W3118166189 startingPage "122" @default.
• W3118166189 abstract "Background and aimsMany patients with hypercholesterolemia fail to achieve sufficient low-density lipoprotein cholesterol (LDL-C) lowering despite use of guideline-recommended lipid-lowering therapies. This study evaluated LDL-C lowering with the combination of bempedoic acid, ezetimibe, and atorvastatin.MethodsThis was a phase 2, randomized, double-blind, placebo-controlled study (NCT03051100). After washout of lipid-lowering drugs, patients were randomized 2:1 to triple therapy (bempedoic acid 180 mg, ezetimibe 10 mg, and atorvastatin 20 mg; n = 43) or placebo (n = 20) once daily for 6 weeks. The primary endpoint was percent change from baseline in LDL-C at week 6.ResultsMean age for the 63 randomized patients was 61.2 years; baseline LDL-C was 154.8 mg/dL. At week 6, mean LDL-C lowering with triple therapy (−63.6%) was significantly greater than with placebo [–3.1%; difference, −60.5% [(95% CI, −68.0% to −53.0%); p < 0.001]. Significant reductions with triple therapy vs. placebo were also observed for non–high-density lipoprotein cholesterol, total cholesterol, apolipoprotein B, and high-sensitivity C-reactive protein (p < 0.001 for all). With triple-therapy, 90% of patients achieved LDL-C <70 mg/dL and 95% of patients had ≥50% lower LDL-C from baseline to week 6; no patients in the placebo group met either goal. The majority of treatment-emergent adverse events were mild to moderate in severity. No patients experienced clinically relevant elevations in aminotransferase or creatine kinase levels.ConclusionsAmong patients with hypercholesterolemia, the combination of bempedoic acid, ezetimibe, and atorvastatin significantly lowered LDL-C, allowing more than 90% of patients in this study to reach guideline-recommended LDL-C goals." @default.
• W3118166189 created "2021-01-05" @default.
• W3118166189 creator A5026508607 @default.
• W3118166189 creator A5033926723 @default.
• W3118166189 creator A5055849986 @default.
• W3118166189 creator A5069181836 @default.
• W3118166189 creator A5078351227 @default.
• W3118166189 date "2021-03-01" @default.
• W3118166189 modified "2023-10-01" @default.
• W3118166189 title "Combination of bempedoic acid, ezetimibe, and atorvastatin in patients with hypercholesterolemia: A randomized clinical trial" @default.
• W3118166189 cites W1968949098 @default.
• W3118166189 cites W1984336544 @default.
• W3118166189 cites W2025041596 @default.
• W3118166189 cites W2057828023 @default.
• W3118166189 cites W2102238081 @default.
• W3118166189 cites W2102899779 @default.
• W3118166189 cites W2111099202 @default.
• W3118166189 cites W2118154631 @default.
• W3118166189 cites W2298508936 @default.
• W3118166189 cites W2465758073 @default.
• W3118166189 cites W2530884669 @default.
• W3118166189 cites W2558991743 @default.
• W3118166189 cites W2594299089 @default.
• W3118166189 cites W2596179513 @default.
• W3118166189 cites W2746706677 @default.
• W3118166189 cites W2784174436 @default.
• W3118166189 cites W2797334809 @default.
• W3118166189 cites W2803546732 @default.
• W3118166189 cites W2806377658 @default.
• W3118166189 cites W2808641584 @default.
• W3118166189 cites W2899997727 @default.
• W3118166189 cites W2921209497 @default.
• W3118166189 cites W2922038538 @default.
• W3118166189 cites W2928534885 @default.
• W3118166189 cites W2941101173 @default.
• W3118166189 cites W2965327853 @default.
• W3118166189 cites W2987850771 @default.
• W3118166189 cites W3040223903 @default.
• W3118166189 cites W3082704660 @default.
• W3118166189 cites W3129818723 @default.
• W3118166189 cites W3183857127 @default.
• W3118166189 doi "https://doi.org/10.1016/j.atherosclerosis.2020.12.023" @default.
• W3118166189 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33514449" @default.
• W3118166189 hasPublicationYear "2021" @default.
• W3118166189 type Work @default.
• W3118166189 sameAs 3118166189 @default.
• W3118166189 citedByCount "35" @default.
• W3118166189 countsByYear W31181661892021 @default.
• W3118166189 countsByYear W31181661892022 @default.
• W3118166189 countsByYear W31181661892023 @default.
• W3118166189 crossrefType "journal-article" @default.
• W3118166189 hasAuthorship W3118166189A5026508607 @default.
• W3118166189 hasAuthorship W3118166189A5033926723 @default.
• W3118166189 hasAuthorship W3118166189A5055849986 @default.
• W3118166189 hasAuthorship W3118166189A5069181836 @default.
• W3118166189 hasAuthorship W3118166189A5078351227 @default.
• W3118166189 hasBestOaLocation W31181661891 @default.
• W3118166189 hasConcept C126322002 @default.
• W3118166189 hasConcept C134018914 @default.
• W3118166189 hasConcept C142724271 @default.
• W3118166189 hasConcept C168563851 @default.
• W3118166189 hasConcept C197934379 @default.
• W3118166189 hasConcept C203092338 @default.
• W3118166189 hasConcept C204787440 @default.
• W3118166189 hasConcept C27081682 @default.
• W3118166189 hasConcept C2776999253 @default.
• W3118166189 hasConcept C2777482532 @default.
• W3118166189 hasConcept C2778163477 @default.
• W3118166189 hasConcept C2778657065 @default.
• W3118166189 hasConcept C62746215 @default.
• W3118166189 hasConcept C71924100 @default.
• W3118166189 hasConcept C90924648 @default.
• W3118166189 hasConceptScore W3118166189C126322002 @default.
• W3118166189 hasConceptScore W3118166189C134018914 @default.
• W3118166189 hasConceptScore W3118166189C142724271 @default.
• W3118166189 hasConceptScore W3118166189C168563851 @default.
• W3118166189 hasConceptScore W3118166189C197934379 @default.
• W3118166189 hasConceptScore W3118166189C203092338 @default.
• W3118166189 hasConceptScore W3118166189C204787440 @default.
• W3118166189 hasConceptScore W3118166189C27081682 @default.
• W3118166189 hasConceptScore W3118166189C2776999253 @default.
• W3118166189 hasConceptScore W3118166189C2777482532 @default.
• W3118166189 hasConceptScore W3118166189C2778163477 @default.
• W3118166189 hasConceptScore W3118166189C2778657065 @default.
• W3118166189 hasConceptScore W3118166189C62746215 @default.
• W3118166189 hasConceptScore W3118166189C71924100 @default.
• W3118166189 hasConceptScore W3118166189C90924648 @default.
• W3118166189 hasLocation W31181661891 @default.
• W3118166189 hasOpenAccess W3118166189 @default.
• W3118166189 hasPrimaryLocation W31181661891 @default.
• W3118166189 hasRelatedWork W1481546673 @default.
• W3118166189 hasRelatedWork W1981345773 @default.
• W3118166189 hasRelatedWork W2025648868 @default.
• W3118166189 hasRelatedWork W2035331946 @default.
• W3118166189 hasRelatedWork W2117255531 @default.
• W3118166189 hasRelatedWork W2124667218 @default.
• W3118166189 hasRelatedWork W2125656906 @default.
• W3118166189 hasRelatedWork W2350152005 @default.

• next